| |
| |
|
| Insider
Information: |
Frenkel Ran |
| Relationship: |
EVP, Chief Dev. Officer |
| City: |
Newton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
168,290 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$181,753 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
168,290 |
|
|
| Total
Value |
$181,753 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-6.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -276.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Karyopharm Therapeutics Inc. |
KPTI |
EVP, Chief Dev. Officer |
2022-02-28 |
168,290 |
2015-04-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Dev. Officer |
• – – |
2022-02-28 |
4 |
S |
$10.24 |
$17,025 |
D/D |
(1,663) |
168,290 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Dev. Officer |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
68,250 |
169,953 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Dev. Officer |
• – – |
2022-02-17 |
4 |
S |
$12.12 |
$35,509 |
D/D |
(2,929) |
101,703 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Dev. Officer |
• – – |
2022-02-07 |
4 |
S |
$9.86 |
$19,635 |
D/D |
(1,991) |
104,632 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Dev. Officer |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
22,013 |
104,439 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Dev. Officer |
• – – |
2021-02-18 |
4 |
S |
$14.83 |
$42,818 |
D/D |
(2,887) |
46,126 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Dev. Officer |
• – – |
2021-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,675 |
49,013 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Dev. Officer |
• – – |
2021-02-11 |
4 |
S |
$15.52 |
$31,752 |
D/D |
(2,046) |
39,338 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, Chief Dev. Officer |
• – – |
2021-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,650 |
41,384 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
Chief Dev Operations Officer |
• – – |
2020-05-07 |
4 |
AS |
$20.00 |
$39,480 |
D/D |
(1,974) |
35,088 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
Chief Dev Operations Officer |
• – – |
2020-02-19 |
4 |
S |
$16.48 |
$49,034 |
D/D |
(2,975) |
36,066 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
Chief Dev Operations Officer |
• – – |
2020-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,675 |
39,041 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
Chief Dev Operations Officer |
• – – |
2017-11-07 |
4 |
S |
$11.25 |
$55,755 |
D/D |
(4,958) |
24,733 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
Chief Dev Operations Officer |
• – – |
2017-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
29,691 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
Chief Dev Operations Officer |
• – – |
2016-11-14 |
4 |
S |
$10.06 |
$33,286 |
D/D |
(3,309) |
14,691 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
Chief Dev Operations Officer |
• – – |
2016-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
18,000 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, WW Development Operations |
• – – |
2015-04-07 |
4 |
B |
$33.00 |
$66,000 |
D/D |
2,000 |
3,000 |
2.74 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, WW Development Operations |
• – – |
2015-04-06 |
4 |
B |
$29.43 |
$29,430 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
